Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0.0523338048090524
Stock impact report

Vaxart to Present at ASM Microbe 2019

Vaxart, Inc. (VXRT) 
Last vaxart, inc. earnings: 3/19 04:01 pm Check Earnings Report
Company Research Source: Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Vaxart, Inc. (NASDAQ: VXRT), a clinical stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that Roberto Mateo, Ph.D., senior scientist at Vaxart, will present preclinical results of its oral Respiratory Syncytial Virus (RSV) vaccine in a poster presentation at the American Society of Microbiology 2019, taking place from June 20-24, 2019 in San Francisco, California. Details of the presentation are as follows:   Poster Title: Oral Adenovirus-Based Vaccine Induces Respiratory MucosalMemory and Protection against Respiratory Syncytial VirusInfection in Cotton Rats Show less Read more
Impact Snapshot
Event Time:
VXRT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for VXRT alerts
Opt-in for
VXRT alerts

from News Quantified
Opt-in for
VXRT alerts

from News Quantified